Pictet Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$162K Hold
10,764
– – ﹤0.01% 2043
2026
Q1
$206K Buy
+10,764
New +$234K ﹤0.01% 1926
2025
Q1
– Sell
-7,465
Closed -$269K – 2073
2024
Q4
$269K Hold
7,465
– – ﹤0.01% 1701
2024
Q3
$317K Hold
7,465
– – ﹤0.01% 1578
2024
Q2
$301K Buy
7,465
+383
+5% +$16K ﹤0.01% 1533
2024
Q1
$251K Hold
7,082
– – ﹤0.01% 1637
2023
Q4
$209K Buy
+7,082
New +$147K ﹤0.01% 1725

Other funds holding TNDM

Pictet Asset Management's TNDM Position: Q2 2026 in Review

Pictet Asset Management held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 10,764 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #2043.

Pictet Asset Management first reported a position in TNDM in Q4 2023 and has held it in 7 quarters since. The position peaked at $317K in Q3 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Pictet Asset Management held 10,764 shares of Tandem Diabetes Care worth $162K as of Q2 2026.
  • Pictet Asset Management left its Tandem Diabetes Care share count unchanged in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #2043 holding.
  • Pictet Asset Management first reported a position in Tandem Diabetes Care in Q4 2023 and has held it in 7 quarters since.
  • Pictet Asset Management's Tandem Diabetes Care position peaked at $317K in Q3 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.